DNAH17, or Dynein Axonemal Heavy Chain 17, is a member of the dynein family of motor proteins. Dyneins are complex protein assemblies that move along microtubules in cells, converting the chemical energy stored in ATP into mechanical work. Specifically, axonemal dyneins, like DNAH17, are responsible for the sliding of microtubules in the axonemes of cilia and flagella, which powers the beating movement of these cellular structures. This beating movement is crucial for various processes, ranging from the movement of single-celled organisms to the transport of mucus out of the human respiratory tract. Given the crucial role of dynein in these processes, the proper function and regulation of proteins like DNAH17 are of paramount importance to cellular and organismal health.
Inhibitors targeting DNAH17 would be chemical entities designed to modulate the activity, function, or stability of the DNAH17 protein. Given its role in axonemal movement, inhibiting DNAH17 could have profound effects on ciliary or flagellar function, potentially impacting movement or transport processes powered by these structures. Potential inhibitors of DNAH17 might include small molecules that bind to the protein, disrupting its ATPase activity, or preventing its interaction with microtubules. This binding could hinder or alter the protein's motor function, leading to changes in the motility or function of cilia and flagella. Another inhibitory strategy might involve molecules that interfere with the assembly or stability of the dynein complex in which DNAH17 resides. Exploring the effects of DNAH17 inhibition can provide valuable insights into its specific roles within the cell, its contributions to ciliary and flagellar function, and its broader impact on processes that rely on these cellular structures. This understanding can also shed light on the broader roles of dynein proteins and their intricate regulation in various cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules, potentially impacting dynein movement and possibly affecting DNAH17 expression. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole disrupts microtubules. As dynein moves along microtubules, its disruption might influence DNAH17 expression. | ||||||
Vinblastine Sulfate | 143-67-9 | sc-201447 sc-201447A sc-201447B sc-201447C | 10 mg 50 mg 100 mg 1 g | $109.00 $412.00 $561.00 $2244.00 | 9 | |
Vinblastine inhibits microtubule formation, which might influence dynein movement and DNAH17 levels. | ||||||
Podophyllotoxin | 518-28-5 | sc-204853 | 100 mg | $84.00 | 1 | |
Podophyllotoxin interferes with microtubule assembly, which might influence dynein function and hence DNAH17 levels. | ||||||
2,3-Butanedione 2-Monoxime | 57-71-6 | sc-203774 sc-203774A sc-203774B sc-203774C | 25 g 100 g 250 g 500 g | $42.00 $78.00 $161.00 $286.00 | ||
BDM affects myosin ATPase activity. While it mainly affects myosin, it might have off-target effects on dynein and impact DNAH17. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Orlistat has been shown to inhibit some cellular enzymes. It might have off-target effects on dynein and DNAH17. | ||||||
Griseofulvin | 126-07-8 | sc-202171A sc-202171 sc-202171B | 5 mg 25 mg 100 mg | $85.00 $220.00 $598.00 | 4 | |
Griseofulvin disrupts microtubule function, which might indirectly influence DNAH17 expression. | ||||||
Albendazole | 54965-21-8 | sc-210771 | 100 mg | $213.00 | 1 | |
Albendazole affects microtubule polymerization and might influence dynein movement and DNAH17 levels. | ||||||